To study the effect of p53 on TME during lung cancer progression, TP53 was knocked out in the EGFRL858R-, and EGFRL858R × TP53−/−-induced lung cancer mouse models (Fig. 4). This evidence concerns the gene TP53 and lung carcinoma.